↑ Top

London · 51.46°N · Running a family office portfolio · building tools

Dr MikeSemenov

Operator and investor with a constant itch to build.

I run investments for a family office: built its brand and the venture, private equity and private credit deal flow behind it, from sourcing to due diligence, with the back office automated. Angel cheques into deeptech through Material Investments since 2023. Before that, four years across Deutsche Bank's technology, data, derivatives and advisory desks, and a PhD in molecular physics at UCL. I still write the code: nine things built, two live, one earning.

01 / Projects

Built, mostly for the fun of it.

A couple live, the rest tried, shipped and shelved. Some with friends. The constant: small, cheap to run, and fun to make.

iOSlive

Stalking detection kit

Live on the App Store and revenue-generating.

An iPhone toolkit for finding hidden cameras and trackers. The one that pays for the others.

Swift

Open sourcelive

Duo

Open source and in use; it produced the PN, SiN and AlH line lists in my papers.

The ExoMol group's Fortran program for computing rovibronic spectra of diatomic molecules. I contributed during my PhD, including the Landé g-factor work. Fortran is still what the physics runs on.

Fortran

Visit

Otherbeta

Automatic crypto trading

Running with real money; verdict on the results to come.

Automated trading strategies, backtested and then let loose on a small book. Partly an excuse to build the pipeline.

Complianceinternal

Family office operating system

Internal; runs the day-to-day for more than one family office.

One system across family offices: CRM, deal flow and document automation, KYC and compliance checks. AI reads and drafts in the background; a human still signs. Built because the off-the-shelf tools assume a single office with a big back office.

Investment · 2022–2024shelved

trendi

Shelved after eighteen months: Europe's VC market was not ready, and the model does not scale like a venture business.

Access to venture funds at smaller ticket sizes, along the lines of Allocate in the US. Co-founded, built, and shut down on purpose rather than left to drift.

SaaSshelved

Patchleads

Shelved: no market fit.

B2B lead feeds built from UK public registers, sold as subscriptions. The data pipeline worked; the buyers did not turn up.

All 9 projects →

02 / Experience

Bank, lab, start-ups, cheque book.

  1. Nov 2023 — now

    Angel Investor · Material Investments INVEST

    Early-stage deeptech, FFF to pre-seed, occasional later rounds.

  2. Jun 2023 — now

    Investment Director (VC, PE & RE) · Family Office INVEST

    Built the office's investment brand from scratch and the venture, private equity, private credit and real estate deal flow behind it: sourcing, due diligence and portfolio management across the US and Europe, with the back office automated.

  3. Sep 2021 — now

    Geek in Residence · Decacorn Capital INVEST

    Technical due diligence on deeptech and AI investments.

  4. Jan 2020 — Jul 2024

    PhD, Theoretical Molecular Physics (with applications of machine learning) · University College London EDU

    ExoMol group (Tennyson, Yurchenko). Variational line lists for PN, SiN and AlH used to read exoplanet atmospheres. Nine papers, four as first author.

  5. Jul 2022 — Jan 2024

    Co-Founder · trendi

    Co-founded a platform giving individuals access to VC funds at smaller tickets, like Allocate in the US. Shut it down after eighteen months: the model does not scale like a venture business, and Europe's VC ecosystem was not ready.

  6. Jul 2022 — Jul 2023

    Investment Analyst · Collective Equity INVEST

    Due diligence on start-ups; advised partners on Fund 1 selection.

  7. Sep 2017 — Jan 2020

    Lead Business Analyst, Origination & Advisory · Deutsche Bank

    Led BA effort across teams on a client-outreach platform; MiFID II, research unbundling and Brexit client documentation; CRM data model.

  8. Mar 2017 — Sep 2017

    Java Developer & Business Analyst, Listed Derivatives · Deutsche Bank

    MiFID II features in the order management system.

earlier → 6 more
  1. Aug 2016 — Mar 2017

    Business Analyst & Salesforce Developer, CDO · Deutsche Bank

    Data models, BRD/FRD, stakeholder workshops, Salesforce modules.

  2. 2012 — 2016

    MSci Physics · University College London EDU

  3. Jun 2015 — Sep 2015

    Summer Intern Analyst, GTO · Deutsche Bank

    FX and credit clearing applications; restructuring projects.

  4. Jun 2014 — Sep 2014

    Communications Analyst & Web Developer · Capital List (Capital Enterprise)

    Built capitallist.co; start-up and VC outreach.

  5. Jul 2011 — Jul 2011

    Research Assistant · Max Planck Institute for Extraterrestrial Physics

    Plasma physics experiments; Fortran code analysing the Collatz conjecture.

  6. 2010 — 2012

    A-Levels: Maths, Further Maths, Computing, Physics · City of London Freemen's School EDU

    Silver, British Physics Olympiad.

03 / Research

Line lists for exoplanet atmospheres.

A line list is the catalogue of light frequencies a molecule absorbs. Telescopes match them against starlight filtered through a planet's atmosphere to say what it is made of. In UCL's ExoMol group I computed them for PN, SiN and AlH from first principles and refined them against laboratory spectra.

First author (04)

  1. 2024

    ExoMol line lists – LXIV. Empirical rovibronic spectra of phosphorous mononitride (PN) covering the IR and UV regions

    Monthly Notices of the Royal Astronomical Society 536(1), 714–727

    M. Semenov, N. El-Kork, S. N. Yurchenko, J. Tennyson

  2. 2022

    ExoMol line lists – XLVI. Empirical rovibronic spectra of silicon mononitrate (SiN) covering the six lowest electronic states and four isotopologues

    Monthly Notices of the Royal Astronomical Society 516(1), 1158–1169

    M. Semenov, N. Clark, S. N. Yurchenko, G.-S. Kim, J. Tennyson

  3. 2021

    Rovibronic spectroscopy of PN from first principles

    Physical Chemistry Chemical Physics 23(38), 22057–22066

    M. Semenov, N. El-Kork, S. N. Yurchenko, J. Tennyson

  4. 2016

    Predicted Landé g-factors for open shell diatomic molecules

    Journal of Molecular Spectroscopy 330, 57–62

    M. Semenov, S. N. Yurchenko, J. Tennyson

Co-author (05)

  1. 2024

    The 2024 release of the ExoMol database: Molecular line lists for exoplanet and other hot atmospheres

    Journal of Quantitative Spectroscopy and Radiative Transfer 326, 109083

    J. Tennyson, S. N. Yurchenko, J. Zhang, C. A. Bowesman, R. P. Brady, J. Buldyreva, K. L. Chubb, et al. incl. M. Semenov

  2. 2023

    Improved potential-energy and dipole-moment functions of the ground electronic state of phosphorus nitride

    Journal of Molecular Spectroscopy 395, 111804

    V. G. Ushakov, M. Semenov, S. N. Yurchenko, A. Y. Ermilov, E. S. Medvedev

  3. 2023

    ExoMol line lists – LIV. Empirical line lists for AlH and AlD and experimental emission spectroscopy of AlD in A¹Π (v = 0, 1, 2)

    Monthly Notices of the Royal Astronomical Society 527(4), 9736–9756

    S. N. Yurchenko, W. Szajna, R. Hakalla, M. Semenov, A. Sokolov, J. Tennyson, R. R. Gamache, Y. Pavlenko, M. R. Schmidt

  4. 2021

    ExoMol line lists – XLIV. Infrared and ultraviolet line list for silicon monoxide (28Si16O)

    Monthly Notices of the Royal Astronomical Society 510(1), 903–919

    S. N. Yurchenko, J. Tennyson, A.-M. Syme, A. Y. Adam, V. H. J. Clark, B. Cooper, C. P. Dobney, et al. incl. M. Semenov

  5. 2020

    The 2020 release of the ExoMol database: Molecular line lists for exoplanet and other hot atmospheres

    Journal of Quantitative Spectroscopy and Radiative Transfer 255, 107228

    J. Tennyson, S. N. Yurchenko, A. F. Al-Refaie, V. H. J. Clark, K. L. Chubb, E. K. Conway, A. Dewan, M. N. Gorman, C. Hill, A. E. Lynas-Gray, T. Mellor, L. K. McKemmish, A. Owens, O. L. Polyansky, M. Semenov, W. Somogyi, G. Tinetti, A. Upadhyay, I. Waldmann, Y. Wang, S. Wright, O. P. Yurchenko

Thesis (01)

  1. 2025

    Theoretical studies of diatomic molecules: line lists for Phosphorus Mononitride, Silicon Mononitride and Aluminium Monohydride

    Doctoral thesis (PhD), University College London

    M. Semenov

04 / Theses

Where I think this is going.

Five things I would bet on. Opinions, with reasons.

  1. 01

    Agents will be entities, the way companies are.

    A company is a fiction we agreed to treat as a person: it can own, contract, sue and be sued, and someone is liable when it misbehaves. Software agents that transact, hire and hold budgets will need the same wrapper, because the user will not be in the loop and the model provider will not accept the liability. Expect registries, capital requirements and something like directors' duties. The legal form will matter more than the model.

  2. 02

    Space is now an industry, and it is staying.

    Launch cost has fallen more than tenfold since the Shuttle and the cadence is weekly, not yearly. That turns orbit from a government programme into a supply chain: manufacturing in microgravity, Earth observation sold by the pixel, communications that bypass terrestrial incumbents. The interesting companies are not building rockets. They are building the boring things that assume the rocket exists: insurance, logistics, data, tooling. That is where the margin was on every previous frontier.

  3. 03

    Millennials will not die of old age.

    Not because of one breakthrough but because of compounding ones: ageing treated as a disease with biomarkers rather than a fact of life, gene editing dosed per patient, organs grown or printed, the first drugs that slow biological clocks already in trials. Someone born in 1990 has sixty years for the science to arrive, and it only needs to arrive in stages. Dying of old age will look like dying of smallpox: a thing that used to happen.

  4. 04

    Personalised medicine is already here.

    In May 2025 an infant in Philadelphia received a base-editing therapy designed for his single mutation, from diagnosis to dose in about six months. That is not a demo; it is a template. Sequencing is cheap, models such as AlphaGenome predict what each variant does, and manufacturing is shrinking to the scale of one. The bottleneck is regulation and reimbursement built for blockbusters. Whoever makes N-of-1 routine rather than heroic owns the next decade of medicine.

    related

  5. 05

    Quantum communication will be standard infrastructure.

    Quantum key distribution already runs on metropolitan fibre in several countries and has been demonstrated by satellite. Once a cryptographically relevant quantum computer is plausible, every bank, government and cloud needs channels that do not depend on hard maths staying hard. That demand does not wait for the computer to exist; it arrives with the insurance premium. Expect it to be bought the way TLS certificates are: invisible, mandatory and boring within ten years.

05 / Signal

Things worth a second look.

Pieces I keep coming back to, with a line on why.

  1. 8 Sep 2026

    Google DeepMind AlphaGenome Atlas: molecular predictions for 9 billion human DNA variants

    A precomputed map of what every possible single-letter change in the genome is predicted to do. Biology is becoming a lookup table.

  2. 21 Jan 2026

    Nature Probing quantum mechanics with nanoparticle matter-wave interferometry

    Matter-wave interference pushed to nanoparticles: the quantum-to-classical boundary tested with objects you can almost see.

  3. 15 May 2025

    Children's Hospital of Philadelphia World's first patient treated with personalised CRISPR gene-editing therapy

    A bespoke base-editing therapy designed, tested and dosed for one infant in about six months. N-of-1 medicine is now real.

  4. 24 Dec 2012

    Wired John McAfee fled to Belize, but he couldn't escape himself

    Joshua Davis's long read on the antivirus founder's unravelling in Belize. Still the best piece on what money without structure does to a person.

Standing feeds

06 / Library

What I would recommend.

A curated selection of what I would hand to a friend to read or watch. I read far more than I watch.

Books

book · 1992

Red Mars

Kim Stanley Robinson

First of the Mars trilogy: the first hundred colonists argue about terraforming, politics and who owns a planet. Hard science fiction with real economics.

Amazon

book · 2016

Tools of Titans

Tim Ferriss

Distilled routines and tactics from a few hundred podcast guests. Best dipped into than read through.

Amazon

book · 1952

East of Eden

John Steinbeck

Two families in the Salinas Valley and the Cain and Abel story retold. Timshel: thou mayest.

Amazon

Films & series

film · 2007

The Man from Earth

Richard Schenkman

A professor tells his colleagues he is 14,000 years old, in one room, in real time. Written by Jerome Bixby on his deathbed; no effects, all argument.

Prime Video

All recommendations →

Amazon links are affiliate links: as an Amazon Associate I earn from qualifying purchases, at no cost to you.

07 / Off-screen

When the laptop is shut.

Make

  • Prototyping and tinkering
  • Theoretical research Collatz conjecture and friends.
  • Reading and writing

Move

Taste

  • Cooking
  • Coffee tasting
  • Wine tasting

08 / Contact

Say hello.

Founders, collaborators, journalists, recruiters: the form takes a minute and I read everything.

Contact form ↗

Clapham, London, United Kingdom. Built with Astro, hosted on Cloudflare, no cookies, no tracking.